Lisa X. Lee

610 total citations
11 papers, 96 citations indexed

About

Lisa X. Lee is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Lisa X. Lee has authored 11 papers receiving a total of 96 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 6 papers in Molecular Biology and 3 papers in Genetics. Recurrent topics in Lisa X. Lee's work include Multiple Myeloma Research and Treatments (4 papers), Chronic Myeloid Leukemia Treatments (3 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (3 papers). Lisa X. Lee is often cited by papers focused on Multiple Myeloma Research and Treatments (4 papers), Chronic Myeloid Leukemia Treatments (3 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (3 papers). Lisa X. Lee collaborates with scholars based in United States, Canada and Qatar. Lisa X. Lee's co-authors include Stefan K. Barta, Shengwen Calvin Li, Cindy Varga, Raymond L. Comenzo, Amandeep Godara, Nauman Siddiqui, Julie Fu, Ping Zhou, Liu Yang and Jorge Monge and has published in prestigious journals such as Blood, Journal of Hematology & Oncology and Materials Chemistry and Physics.

In The Last Decade

Lisa X. Lee

8 papers receiving 94 citations

Peers

Lisa X. Lee
Jared Henderson United States
Jennifer A. Arzt United States
Gulrukh Ahsan United Kingdom
Eisuke Shono Japan
Hannah McCalmont Australia
Jakob Matthes Germany
Myrna Nahas United States
Harry Miao United States
Esther Hian Li Chan Singapore
Jared Henderson United States
Lisa X. Lee
Citations per year, relative to Lisa X. Lee Lisa X. Lee (= 1×) peers Jared Henderson

Countries citing papers authored by Lisa X. Lee

Since Specialization
Citations

This map shows the geographic impact of Lisa X. Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa X. Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa X. Lee more than expected).

Fields of papers citing papers by Lisa X. Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa X. Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa X. Lee. The network helps show where Lisa X. Lee may publish in the future.

Co-authorship network of co-authors of Lisa X. Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa X. Lee. A scholar is included among the top collaborators of Lisa X. Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa X. Lee. Lisa X. Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
2.
Nahmias, Jeffry, Lisa X. Lee, Matthew Dolich, et al.. (2024). Leukocytosis and thrombocytosis after splenectomy: expected finding, infection, or something else: a case report. Journal of Medical Case Reports. 18(1). 499–499.
3.
hadad, Amir A. El, Mohamed A. Mezour, Samar Shurbaji, et al.. (2024). 2D magnesium phosphate resorbable coating to enhance cell adhesion on titanium surfaces. Materials Chemistry and Physics. 316. 129114–129114. 5 indexed citations
4.
Tran, Minh‐Ha, et al.. (2023). Caplacizumab as rescue therapy in refractory TTP involving neurologic features. Transfusion and Apheresis Science. 62(3). 103656–103656. 1 indexed citations
5.
Bahlis, Nizar J., Suzanne Trudel, Christopher Maisel, et al.. (2023). Safety of Elranatamab in Patients with Triple-Class Refractory Relapsed/Refractory Multiple Myeloma (RRMM) in Magnetismm-17, a North American Expanded Access Protocol. Blood. 142(Supplement 1). 6737–6737.
6.
Lee, Lisa X. & Shengwen Calvin Li. (2020). Hunting down the dominating subclone of cancer stem cells as a potential new therapeutic target in multiple myeloma: An artificial intelligence perspective. World Journal of Stem Cells. 12(8). 706–720. 17 indexed citations
7.
Godara, Amandeep, et al.. (2020). Dual Monoclonal Antibody Therapy in Patients With Systemic AL Amyloidosis and Cardiac Involvement. Clinical Lymphoma Myeloma & Leukemia. 20(3). 184–189. 17 indexed citations
8.
Fu, Julie, et al.. (2019). A Case of T-Cell Large Granular Lymphocytic Leukemia and Renal Immunoglobulin Heavy Chain Amyloidosis. American Journal of Case Reports. 20. 43–47. 4 indexed citations
9.
Ma, Xun, Ping Zhou, Lisa X. Lee, et al.. (2018). Effective Lipidoid Nanoparticle Delivery In Vivo of siRNA Targeting Kappa Light Chain Production in a Murine Xenograft Model. Blood. 132(Supplement 1). 3208–3208. 2 indexed citations
10.
11.
Lee, Lisa X., et al.. (2014). New antibody approaches to lymphoma therapy. Journal of Hematology & Oncology. 7(1). 58–58. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jared Henderson Breakdown of academic impact, for papers by Jennifer A. Arzt Breakdown of academic impact, for papers by Gulrukh Ahsan Breakdown of academic impact, for papers by Eisuke Shono Breakdown of academic impact, for papers by Hannah McCalmont Breakdown of academic impact, for papers by Jakob Matthes Breakdown of academic impact, for papers by Myrna Nahas Breakdown of academic impact, for papers by Harry Miao Breakdown of academic impact, for papers by Esther Hian Li Chan
Rankless by CCL
2026